The report will be delivered in 2-3 business days.

Breast Cancer Diagnostics Market Global Report 2020-30: Covid 19 Growth and Change

Starting Price : $ 4000.00 | Pages : 150 | Published : August 2020 | SKU CODE : 7655 | Format :


The breast cancer diagnostics market consists of sales of breast cancer diagnostic devices and related services by entities (organizations, sole traders and partnerships) that produce breast cancer diagnostics devices. These devices are used to diagnose breast cancer. Only goods and services traded between entities or sold to end consumers are included.

The global breast cancer diagnostics market is expected to decline from $4.88 billion in 2019 to $4.62 billion in 2020 at a compound annual growth rate (CAGR) of -5.38%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, especially postponement of non-emergency procedures. The market is then expected to recover and reach $6.32 billion in 2023 at a CAGR of 10.99%.

North America was the largest region for breast cancer diagnostics market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The increasing incidence of breast cancer will require more equipment to diagnose, which will further increase the demand for breast cancer diagnostics market. Breast cancer is the most common form of cancer, affecting 2.1 million women every year, and furthermore causing the largest number of deaths from cancer in women. The goal of the early diagnosis is to improve the percentage of breast cancers diagnosed at an initial point so that more successful care will be used and the risk of death from breast cancer can be reduced. According to the World Health Organization (WHO), 627,000 people died of breast cancer in 2018, which is about 15% of all cancer deaths in women. Therefore, the increasing incidence of breast cancer is expected to drive the growth of the breast cancer diagnostics market.

The high cost of diagnosis of breast cancer is a key factor that hinders the growth of the market for diagnostics of breast cancer. The cost of diagnosis for breast cancer typically rose with the initiation of the diagnostic stage of the disease. According to a 2019 study conducted by Mesothelioma Center, around 63% of respondents that comprise of people with cancer and their family members reported financial difficulties. For instance, the total cost of diagnosis for breast cancer was $353 per patient but diagnostic costs varied from $151 in some regions to $751 in others. Therefore, the high-cost diagnosis of breast cancer makes the process a distant option and hinders the growth of the breast cancer diagnostics market.

The technological advancement is a key trend in the breast cancer diagnostics market. Several new techniques have been developed which could be used in the diagnosis and treatment of breast cancer. The 3D mammography, also known as breast tomosynthesis, takes photographs around the breast from various angles and translates them into a 3-D model. In March 2019, Southwest Medical Center, a US-based company, launched 3D mammography services that provide patients with access to enhanced breast imaging services closer to home.

In November 2019, EXACT Sciences Corporation, a US-based molecular diagnostics company, acquired Genomic Health for $2.8 billion. Through this acquisition, Exact Sciences will be able to facilitate therapy decisions for colorectal, breast and prostate cancers by Genomic Health’s Oncotype DX gene expression. Genomic Health is a US-based genomic diagnostics manufacturer.

The major players covered in the breast cancer diagnostics market report are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, C. R. Bard Inc, Gamma Medica Inc, Aurora Imaging Technology Inc, Dilion Technologies Inc, Genomic Health, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc, Leica Biosystems Nussloch GmbH, bioTheranostics Inc, Bio-Rad Laboratories Inc, Illumina Inc, Biocept Inc, Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated.

The countries covered in the breast cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

1)By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Others 2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies 3) By Cancer Type: BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Others 4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies 5) By End Users: Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

    1. Executive Summary

    2. Breast Cancer Diagnostics Market Characteristics

    3. Breast Cancer Diagnostics Market Size And Growth

    3.1. Global Breast Cancer Diagnostics Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Breast Cancer Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Breast Cancer Diagnostics Market Segmentation

    4.1. Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Imaging

    Biopsy

    Genomic Tests

    Blood Tests

    Others

    4.2. Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Fluorescent In Situ Hybridization (FISH)

    Comparative Genomic Hybridization (CGH)

    Immunohistochemical (IHC)

    Other Technologies

    4.3. Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    BRCA Breast Cancer

    ER & PR Breast Cancer

    HER 2 Breast Cancer

    EGFR Mutation Test Breast Cancer

    Others

    4.4. Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Ionizing Breast Imaging Technologies

    Non-ionizing Imaging Technologies

    4.5. Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospitals and Clinics

    Cancer Research Centers

    Diagnostic Laboratories

    Ambulatory Surgical Centers

    5. Breast Cancer Diagnostics Market Regional And Country Analysis

    5.1. Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Breast Cancer Diagnostics Market

    6.1. Asia-Pacific Breast Cancer Diagnostics Market Overview

    6.2. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Breast Cancer Diagnostics Market

    7.1. China Breast Cancer Diagnostics Market Overview

    7.2. China Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.3. China Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Breast Cancer Diagnostics Market

    8.1. India Breast Cancer Diagnostics Market Overview

    8.2. India Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Breast Cancer Diagnostics Market

    9.1. Japan Breast Cancer Diagnostics Market Overview

    9.2. Japan Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Breast Cancer Diagnostics Market

    10.1. Australia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Breast Cancer Diagnostics Market

    11.1. Indonesia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Breast Cancer Diagnostics Market

    12.1. South Korea Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Breast Cancer Diagnostics Market

    13.1. Western Europe Breast Cancer Diagnostics Market Overview

    13.2. Western Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Breast Cancer Diagnostics Market

    14.1. UK Breast Cancer Diagnostics Market Overview

    14.2. UK Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Breast Cancer Diagnostics Market

    15.1. Germany Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Breast Cancer Diagnostics Market

    16.4. France Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.5. France Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Breast Cancer Diagnostics Market

    17.1. Eastern Europe Breast Cancer Diagnostics Market Overview

    17.2. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Breast Cancer Diagnostics Market

    18.1. Russia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Breast Cancer Diagnostics Market

    19.1. North America Breast Cancer Diagnostics Market Overview

    19.2. North America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Breast Cancer Diagnostics Market

    20.1. USA Breast Cancer Diagnostics Market Overview

    20.2. USA Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Breast Cancer Diagnostics Market

    21.1. South America Breast Cancer Diagnostics Market Overview

    21.2. South America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Breast Cancer Diagnostics Market

    22.1. Brazil Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Breast Cancer Diagnostics Market

    23.1. Middle East Breast Cancer Diagnostics Market Overview

    23.2. Middle East Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Breast Cancer Diagnostics Market

    24.1. Africa Breast Cancer Diagnostics Market Overview

    24.2. Africa Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Breast Cancer Diagnostics Market Competitive Landscape And Company Profiles

    25.1. Breast Cancer Diagnostics Market Competitive Landscape

    25.2. Breast Cancer Diagnostics Market Company Profiles

    25.2.1. Abbott Laboratories

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Myriad Genetics Inc

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Hologic Inc

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Koninklijke Philips N.V.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Fujifilm Holdings Corporation

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Breast Cancer Diagnostics Market

    27. Breast Cancer Diagnostics Market Trends And Strategies

    28. Breast Cancer Diagnostics Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: China, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: China, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: India, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: India, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Japan, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Australia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Australia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: Indonesia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: Indonesia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: South Korea, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: South Korea, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Western Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Western Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: UK, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: UK, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: Germany, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: Germany, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: France, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: France, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: Russia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: Russia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: North America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: North America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: USA, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: USA, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: South America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: South America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Brazil, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Brazil, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Middle East, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: Middle East, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 46: Africa, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 47: Africa, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 48: Abbott Laboratories Financial Performance
  • Table 49: Myriad Genetics Inc Financial Performance
  • Table 50: Hologic Inc Financial Performance
  • Table 51: Koninklijke Philips N.V. Financial Performance
  • Table 52: Fujifilm Holdings Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: China, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: China, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: India, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: India, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Japan, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Australia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Australia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: Indonesia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: South Korea, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: South Korea, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Western Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: UK, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: UK, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: Germany, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: Germany, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: France, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: France, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: Russia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: Russia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: North America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: North America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: USA, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: USA, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: South America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: South America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Brazil, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Brazil, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Middle East, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: Middle East, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 46: Africa, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 47: Africa, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 48: Abbott Laboratories Financial Performance
  • Figure 49: Myriad Genetics Inc Financial Performance
  • Figure 50: Hologic Inc Financial Performance
  • Figure 51: Koninklijke Philips N.V. Financial Performance
  • Figure 52: Fujifilm Holdings Corporation Financial Performance
Development Of Alternative Products In The Blood Glucose Test Strips Market- Silk Strips, Continuous Test Tapes
The Refractive Surgery Devices And Equipment Industry Will Reach $1.18 Billion By 2022
High Risk Of Diabetic Patients Suffering From The Coronavirus Has Led To Increased Demand For POC HbA1C Testing
Increasing Adoption Of Neurological Devices Over Drug Therapies
Resmed And General Electric Company- Leaders In The Anesthesia And Respiratory Devices Market
Increase In Collaborations And Partnerships In The Medical Sensors Market
Smart Inhalers And Wearables For Patients Suffering From Respiratory Diseases
Tobacco Smoking, Sleep Apnea, And Changing Climate Conditions Are Increasing The Demand For Respiratory Devices
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2020-30: Covid 19 Growth and Change
View Report
Methanol Market - By End Use (Formaldehyde, Mto/Mtp, Fuel Blending, Dimethyl Ether, Acetic Acid, Methyl Tert-Butyl Ether (Mtbe), Solvents, Methylamines, Mma, Chloro-Methanes, And Others), By Type Of Product( Plastics & Polymers, Chlor-Alkali And Inorganics, Olefins, Aromatics, Olefin Derivatives, Syngas Chemicals), Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Market - By Type (N95 Respirators, Common Grade Surgical Masks And Non-Medical Grade Respiratory Masks), By End-User (Hospitals And Clinics, Individual, Industrial, And Others), By Distribution Channel (Hospitals, Retail And Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Portable Ultrasound Devices Market - By Segments (Mobile Ultrasound Devices And Handheld Ultrasound Devices), By End User ( Cardiovascular, Obstetrics / Gynecology, Gastro, Musculoskeletal And Point Of Care / Others), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Portable X-Ray Devices Market - By Segments (Mobile X-Ray Devices, Handheld X-Ray Devices), By Types (Computed Radiography X-Ray Devices, Digital X-Ray Devices And Analog X-Ray), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Disposable Hospital Supplies Market Global Report 2020-30: COVID 19 Implications and Growth
View Report
Sterilization Equipment and Disinfectants Market Global Report 2020-30: COVID 19 Implications and Growth
View Report
Nebulizers Market - By Type Of Devices (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer), By Application (Copd, Cystic Fibrosis, Asthma, Others), By Portability (Tabletop, Portable), By End-User (Hospitals And Clinics, Emergency Centers, Home Healthcare), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)